Table of Contents

company-logo

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPlus, a blend of NanoStilbene and Nano Cannabidiol; Nano Cannabidiol, a nanoparticle formulation of cannabidiol; NanoPSA, a blend of NanoStilbene and broccoli sprout extract; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. It is also developing therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho.

Therapeutic Solutions International Dividend Announcement

• Therapeutic Solutions International does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Therapeutic Solutions International dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Therapeutic Solutions International Dividend History

Therapeutic Solutions International Dividend Yield

Therapeutic Solutions International current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Therapeutic Solutions International stock? Use our calculator to estimate your expected dividend yield:

Therapeutic Solutions International Financial Ratios

P/E ratio-0.00
PEG ratio0.00
P/B ratio0.00
ROE-189.05%
Payout ratio0.00%
Current ratio271.27
Quick ratio261.94
Cash Ratio0.01

Therapeutic Solutions International Dividend FAQ

Does Therapeutic Solutions International stock pay dividends?
Therapeutic Solutions International does not currently pay dividends to its shareholders.
Has Therapeutic Solutions International ever paid a dividend?
No, Therapeutic Solutions International has no a history of paying dividends to its shareholders. Therapeutic Solutions International is not known for its dividend payments.
Why doesn't Therapeutic Solutions International pay dividends?
There are several potential reasons why Therapeutic Solutions International would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Therapeutic Solutions International ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Therapeutic Solutions International has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Therapeutic Solutions International a dividend aristocrat?
Therapeutic Solutions International is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Therapeutic Solutions International a dividend king?
Therapeutic Solutions International is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Therapeutic Solutions International a dividend stock?
No, Therapeutic Solutions International is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Therapeutic Solutions International stocks?
To buy Therapeutic Solutions International you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Therapeutic Solutions International stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.